Mesoblast (MESO) has named James M. O’Brien as its US-based Chief Financial Officer, effective immediately. Mr. O'Brien brings extensive experience in financial management and planning, having spent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback